Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
1997 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.
Clin Cancer Res. 1997 Aug;3(8):1277-88.
Clin Cancer Res. 1997.
PMID: 9815810
Clinical Trial.
Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma.
Albertini MR, Gan J, Jaeger P, Hank JA, Storer B, Schell K, Rivest T, Surfus J, Reisfeld RA, Schiller JH, Sondel PM.
Albertini MR, et al.
J Immunother Emphasis Tumor Immunol. 1996 Jul;19(4):278-95. doi: 10.1097/00002371-199607000-00004.
J Immunother Emphasis Tumor Immunol. 1996.
PMID: 8877722
Item in Clipboard
Cite
Cite